Pharmafile Logo

It’s time to measure outcomes

Lucid launch their new metrics platform

- PMLiVE

With shrinking budgets and shorter timelines, pharmaceutical companies are keen to invest their assets smartly in medical education programmes that will guarantee their desired outcomes. Medical communications have aimed to keep pace with this development through evaluation forms and post-event surveys. However, these usually measure the level of audience satisfaction, rather than our actual progress towards our ultimate goal. In the latest issue of PME, Dennis O’Brien (Lucid Co-founder and CEO) discusses the need to demonstrate that medical education programmes are truly achieving what they promise.

“It’s time to think of new ways of measuring effectiveness, particularly relating to outcomes,” says Dennis. He comments on the frequent use of patient information leaflets: “If we haven’t got evidence that it improves patient outcomes, then we shouldn’t be doing it. Let’s invest our time where it matters.”

Dennis explains Lucid’s new solution to this challenge of measuring outcomes: “Our latest methodology at Lucid is a metrics platform. It provides a strategic approach to education that starts by defining our WHY – the outcomes we want to achieve. We then look at what behaviours we need in our audience to get us there. Where once we thought it was only our medicines that could improve outcomes, we can now demonstrate that it’s our services and our communications that make a difference.”

To read Dennis’ full article, click the following link: http://www.pmlive.com/__data/assets/pdf_file/0004/1199893/45_Lucid_TL.pdf

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

International Women's Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...